Surgical Science Sweden akcijos akcijų analizė | Akcijų kaina | Naujienos | SUS.ST | SE0014428512 | A2P46G

Data	Surgical Science Sweden Akcijų kaina
2024-09-06	114,20 SEK
2024-09-05	116,30 SEK
2024-09-04	113,70 SEK
2024-09-03	116,80 SEK
2024-09-02	120,00 SEK
2024-08-30	124,00 SEK
2024-08-29	127,60 SEK
2024-08-28	126,00 SEK
2024-08-27	127,40 SEK
2024-08-26	134,20 SEK
2024-08-23	129,50 SEK
2024-08-22	130,90 SEK
2024-08-21	126,40 SEK
2024-08-20	133,90 SEK
2024-08-19	134,00 SEK
2024-08-16	135,00 SEK
2024-08-15	137,10 SEK
2024-08-14	130,00 SEK
2024-08-13	130,00 SEK
2024-08-12	129,30 SEK

Data	Surgical Science Sweden Pajamos	Surgical Science Sweden EBIT	Surgical Science Sweden Pelnas
2029e	2,39 mlrd. SEK	0 SEK	0 SEK
2028e	2,02 mlrd. SEK	0 SEK	0 SEK
2027e	1,69 mlrd. SEK	0 SEK	0 SEK
2026e	1,35 mlrd. SEK	474,20 mln. SEK	379,41 mln. SEK
2025e	1,13 mlrd. SEK	353,10 mln. SEK	271,29 mln. SEK
2024e	934,45 mln. SEK	225,23 mln. SEK	176,67 mln. SEK
2023	882,85 mln. SEK	189,15 mln. SEK	233,97 mln. SEK
2022	802,54 mln. SEK	162,54 mln. SEK	187,97 mln. SEK
2021	366,78 mln. SEK	56,52 mln. SEK	86,25 mln. SEK
2020	104,80 mln. SEK	19,97 mln. SEK	15,61 mln. SEK
2019	101,52 mln. SEK	15,18 mln. SEK	12,60 mln. SEK
2018	65,70 mln. SEK	−4,07 mln. SEK	−4,52 mln. SEK
2017	57,34 mln. SEK	−4,19 mln. SEK	−2,58 mln. SEK
2016	51,84 mln. SEK	−229 730,00 SEK	3,27 mln. SEK
2015	46,12 mln. SEK	1,82 mln. SEK	1,62 mln. SEK
2014	28,47 mln. SEK	1,50 mln. SEK	1,41 mln. SEK

	Pajamos	EBIT	Pelnas
2014	28,47 mln. SEK	1,50 mln. SEK	1,41 mln. SEK
2015	46,12 mln. SEK	1,82 mln. SEK	1,62 mln. SEK
2016	51,84 mln. SEK	−229 730,00 SEK	3,27 mln. SEK
2017	57,34 mln. SEK	−4,19 mln. SEK	−2,58 mln. SEK
2018	65,70 mln. SEK	−4,07 mln. SEK	−4,52 mln. SEK
2019	101,52 mln. SEK	15,18 mln. SEK	12,60 mln. SEK
2020	104,80 mln. SEK	19,97 mln. SEK	15,61 mln. SEK
2021	366,78 mln. SEK	56,52 mln. SEK	86,25 mln. SEK
2022	802,54 mln. SEK	162,54 mln. SEK	187,97 mln. SEK
2023	882,85 mln. SEK	189,15 mln. SEK	233,97 mln. SEK
2024e	934,45 mln. SEK	225,23 mln. SEK	176,67 mln. SEK
2025e	1,13 mlrd. SEK	353,10 mln. SEK	271,29 mln. SEK
2026e	1,35 mlrd. SEK	474,20 mln. SEK	379,41 mln. SEK
2027e	1,69 mlrd. SEK	0 SEK	0 SEK
2028e	2,02 mlrd. SEK	0 SEK	0 SEK
2029e	2,39 mlrd. SEK	0 SEK	0 SEK

2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e	2027e	2028e	2029e
0,03	0,05	0,05	0,06	0,07	0,10	0,10	0,37	0,80	0,88	0,93	1,13	1,35	1,69	2,02	2,39
-	64,29	10,87	11,76	14,04	55,38	2,97	251,92	119,13	9,98	5,90	20,77	19,33	25,26	19,99	17,99
121,43	113,04	113,73	107,02	75,38	82,18	84,62	72,40	66,21	69,39	-	-	-	-	-	-
34,00	52,00	58,00	61,00	49,00	83,00	88,00	265,00	531,00	612,00	0	0	0	0	0	0
1,00	1,00	0	−4,00	−4,00	15,00	19,00	56,00	162,00	189,00	225,00	353,00	474,00	0	0	0
3,57	2,17	-	−7,02	−6,15	14,85	18,27	15,30	20,20	21,43	24,09	31,29	35,22	-	-	-
1,00	1,00	3,00	−2,00	−4,00	12,00	15,00	86,00	187,00	233,00	176,00	271,00	379,00	0	0	0
-	-	200,00	−166,67	100,00	−400,00	25,00	473,33	117,44	24,60	−24,46	53,98	39,85	-	-	-
2,86	14,32	14,32	19,32	24,32	29,05	34,37	42,67	50,91	50,94	0	0	0	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

2014	2015	2016	2017	2018	2019	2020	2021	2022	2023

0,10	2,03	3,77	38,54	38,50	69,22	87,16	316,68	433,73	634,37
14,30	12,93	12,92	8,15	12,30	29,53	27,54	157,47	226,33	172,86
2,40	4,38	4,17	2,75	2,70	2,94	4,54	22,32	17,80	18,85
3,20	3,85	5,94	8,44	4,75	7,19	12,46	113,11	134,88	154,45
0,70	1,66	0,43	1,67	1,57	3,90	1,70	7,33	13,63	10,67
20,70	24,84	27,22	59,55	59,81	112,77	133,39	616,91	826,37	991,19
1,60	1,50	1,41	3,03	3,63	9,07	8,55	38,39	51,36	76,62
0	0	0	0	0	0,21	0,21	4,97	4,37	4,77
0	0	0	0	0	41,63	37,25	125,75	67,81	0
27,00	28,37	31,32	27,57	25,49	66,70	62,90	274,03	301,02	286,57
0	0	0	0,01	0,01	0,26	0,26	3,02	3,44	3,33
0	0	3,74	6,13	5,68	6,97	6,72	24,60	22,16	14,84
0,03	0,03	0,04	0,04	0,04	0,39	0,38	3,49	3,89	3,71
0,05	0,05	0,06	0,10	0,10	0,50	0,51	4,10	4,72	4,70

0,70	0,72	0,72	1,22	1,22	1,68	1,73	2,54	2,54	2,55
0	0,04	0,04	0,11	0,11	0,42	0,43	3,38	3,38	3,40
−23,00	−22,17	−19,43	−23,48	−28,77	−16,32	−0,29	203,55	854,93	944,54
0,04	0	0	0	0	0,42	0,43	3,59	0,58	0
0	0	0	0	0	0	0	0	0	0
0,02	0,02	0,02	0,08	0,08	0,82	0,85	7,17	4,82	4,35
3,40	3,54	2,00	3,64	3,20	2,37	2,30	34,37	65,69	41,29
3,40	3,91	6,89	8,67	7,17	14,27	14,81	104,18	44,27	47,34
3,40	2,32	4,34	1,90	5,53	22,95	14,17	81,03	180,87	133,07
1,50	3,70	8,93	0	0	0	0	0	0	0
0	0	0	0	0	0	0	12,79	15,08	13,24
11,70	13,47	22,17	14,21	15,90	39,58	31,28	232,38	305,91	234,94
0	0	0	4,04	4,37	5,53	4,29	12,07	14,68	40,02
0	0	0	0	0	9,42	9,66	48,51	51,51	45,00
18,90	21,60	19,15	0	0	0	0	100,11	41,02	37,50
18,90	21,60	19,15	4,04	4,37	14,96	13,95	160,68	107,20	122,52
30,60	35,07	41,31	18,24	20,28	54,54	45,22	393,06	413,11	357,46
0,05	0,05	0,06	0,10	0,10	0,87	0,90	7,56	5,23	4,70

2015	2016	2017	2018	2019	2020	2021	2022	2023
1,00	0	−4,00	−4,00	15,00	19,00	56,00	162,00	189,00
7,00	8,00	10,00	10,00	15,00	16,00	33,00	51,00	0
0	0	0	0	0	0	0	0	0
0	5,00	0	1,00	24,00	−14,00	−50,00	−73,00	−11,00
0	0	0	0	0	1,00	0	−11,00	61,00
0	0	0	0	0	0	0	0	0
0	0	0	0	0	9,00	3,00	8,00	14,00
7,00	13,00	7,00	6,00	55,00	23,00	39,00	129,00	238,00
−8,00	−11,00	−8,00	−8,00	−8,00	−8,00	−14,00	−34,00	−44,00
−8,00	−11,00	−13,00	−8,00	−210,00	−8,00	−2 732,00	−34,00	−44,00
0	0	−5,00	0	−201,00	0	−2 718,00	0	0
0	0	0	0	0	0	0	0	0
2,00	0	−4,00	0	−4,00	−5,00	−31,00	17,00	−3,00
0	0	0,06	0,00	0,19	0,01	2,95	0	0,02
0,00	0	0,04	0,00	0,19	0,00	2,92	0,02	0,02
-	-	−19,00	-	-	-	-	-	-
0	0	0	0	0	0	0	0	0
1,00	1,00	34,00	0	30,00	17,00	229,00	117,00	200,00
−0,82	1,74	−1,11	−1,76	46,29	14,53	24,71	94,94	194,16
0	0	0	0	0	0	0	0	0

Surgical Science Sweden Bruto marža	Surgical Science Sweden Pelnas-martža	Surgical Science Sweden EBIT marža	Surgical Science Sweden Pelnas-martža
2029e	69,42 %	0 %	0 %
2028e	69,42 %	0 %	0 %
2027e	69,42 %	0 %	0 %
2026e	69,42 %	35,23 %	28,19 %
2025e	69,42 %	31,28 %	24,03 %
2024e	69,42 %	24,10 %	18,91 %
2023	69,42 %	21,43 %	26,50 %
2022	66,23 %	20,25 %	23,42 %
2021	72,51 %	15,41 %	23,52 %
2020	84,32 %	19,06 %	14,89 %
2019	82,33 %	14,95 %	12,41 %
2018	74,84 %	−6,19 %	−6,88 %
2017	107,23 %	−7,31 %	−4,49 %
2016	112,20 %	−0,44 %	6,31 %
2015	113,75 %	3,95 %	3,52 %
2014	120,65 %	5,27 %	4,95 %

	Bruto marža	EBIT marža	Pelnas-martža
2014	120,65 %	5,27 %	4,95 %
2015	113,75 %	3,95 %	3,52 %
2016	112,20 %	−0,44 %	6,31 %
2017	107,23 %	−7,31 %	−4,49 %
2018	74,84 %	−6,19 %	−6,88 %
2019	82,33 %	14,95 %	12,41 %
2020	84,32 %	19,06 %	14,89 %
2021	72,51 %	15,41 %	23,52 %
2022	66,23 %	20,25 %	23,42 %
2023	69,42 %	21,43 %	26,50 %
2024e	69,42 %	24,10 %	18,91 %
2025e	69,42 %	31,28 %	24,03 %
2026e	69,42 %	35,23 %	28,19 %
2027e	69,42 %	0 %	0 %
2028e	69,42 %	0 %	0 %
2029e	69,42 %	0 %	0 %

Data	Surgical Science Sweden Pardavimai vienai akcijai	Surgical Science Sweden EBIT vienai akcijai	Surgical Science Sweden Pelnas vienai akcijai
2029e	46,78 SEK	0 SEK	0 SEK
2028e	39,65 SEK	0 SEK	0 SEK
2027e	33,04 SEK	0 SEK	0 SEK
2026e	26,38 SEK	0 SEK	7,44 SEK
2025e	22,13 SEK	0 SEK	5,32 SEK
2024e	18,31 SEK	0 SEK	3,46 SEK
2023	17,33 SEK	3,71 SEK	4,59 SEK
2022	15,76 SEK	3,19 SEK	3,69 SEK
2021	8,60 SEK	1,32 SEK	2,02 SEK
2020	3,05 SEK	0,58 SEK	0,45 SEK
2019	3,49 SEK	0,52 SEK	0,43 SEK
2018	2,70 SEK	−0,17 SEK	−0,19 SEK
2017	2,97 SEK	−0,22 SEK	−0,13 SEK
2016	3,62 SEK	−0,02 SEK	0,23 SEK
2015	3,22 SEK	0,13 SEK	0,11 SEK
2014	9,95 SEK	0,52 SEK	0,49 SEK

	Pardavimai vienai akcijai	EBIT vienai akcijai	Pelnas vienai akcijai
2014	9,95 SEK	0,52 SEK	0,49 SEK
2015	3,22 SEK	0,13 SEK	0,11 SEK
2016	3,62 SEK	−0,02 SEK	0,23 SEK
2017	2,97 SEK	−0,22 SEK	−0,13 SEK
2018	2,70 SEK	−0,17 SEK	−0,19 SEK
2019	3,49 SEK	0,52 SEK	0,43 SEK
2020	3,05 SEK	0,58 SEK	0,45 SEK
2021	8,60 SEK	1,32 SEK	2,02 SEK
2022	15,76 SEK	3,19 SEK	3,69 SEK
2023	17,33 SEK	3,71 SEK	4,59 SEK
2024e	18,31 SEK	0 SEK	3,46 SEK
2025e	22,13 SEK	0 SEK	5,32 SEK
2026e	26,38 SEK	0 SEK	7,44 SEK
2027e	33,04 SEK	0 SEK	0 SEK
2028e	39,65 SEK	0 SEK	0 SEK
2029e	46,78 SEK	0 SEK	0 SEK

	Akcijų skaičius
2014	2,86 mln. Aktien
2015	14,32 mln. Aktien
2016	14,32 mln. Aktien
2017	19,32 mln. Aktien
2018	24,32 mln. Aktien
2019	29,05 mln. Aktien
2020	34,37 mln. Aktien
2021	42,67 mln. Aktien
2022	50,91 mln. Aktien
2023	50,94 mln. Aktien
2024e	50,94 mln. Aktien
2025e	50,94 mln. Aktien
2026e	50,94 mln. Aktien
2027e	50,94 mln. Aktien
2028e	50,94 mln. Aktien
2029e	50,94 mln. Aktien

Data	EPS-prognozė	EPS-Faktinis	Pranešimo ketvirtis
2024-06-30	0,74 SEK	0,56 SEK (−24,82 %)	2024 Q2
2024-03-31	0,88 SEK	0,47 SEK (−46,51 %)	2024 Q1
2023-12-31	1,23 SEK	1,92 SEK (56,45 %)	2023 Q4
2023-09-30	0,71 SEK	0,93 SEK (30,14 %)	2023 Q3
2023-06-30	0,82 SEK	0,76 SEK (−7,10 %)	2023 Q2
2023-03-31	0,54 SEK	0,98 SEK (82,22 %)	2023 Q1
2022-12-31	0,83 SEK	2,29 SEK (176,50 %)	2022 Q4
2022-09-30	0,63 SEK	0,56 SEK (−11,29 %)	2022 Q3
2022-06-30	0,51 SEK	0,52 SEK (2,97 %)	2022 Q2
2022-03-31	0,40 SEK	0,32 SEK (−20,79 %)	2022 Q1
2021-12-31	0,56 SEK	1,31 SEK (135,82 %)	2021 Q4
2021-09-30	0,20 SEK	0,33 SEK (63,37 %)	2021 Q3
2021-06-30	0,15 SEK	0,09 SEK (−40,59 %)	2021 Q2
2021-03-31	0,07 SEK	0,04 SEK (−43,42 %)	2021 Q1
2020-12-31	0,31 SEK	0,31 SEK (−0,99 %)	2020 Q4
2020-09-30	0,08 SEK	0,17 SEK (110,40 %)	2020 Q3

%	Pavadinimas	Akcijos	Pokytis	Data
7,58440 %	Handelsbanken Kapitalförvaltning AB	3 870 029	355 100	2024-02-29
6,41070 %	Capital Research Global Investors	3 271 137	0	2024-02-29
6,13244 %	Swedbank Robur Fonder AB	3 129 149	−183 439	2024-02-29
5,97140 %	TIN Fonder	3 046 977	0	2023-02-28
5,43986 %	Fjärde AP-Fonden	2 775 753	100 000	2024-02-29
4,99932 %	KIRKBI Invest A/S	2 550 961	0	2024-02-29
2,13559 %	Montanaro Asset Management Limited	1 089 711	−104 066	2024-02-29
13,98962 %	Marknadspotential AB	7 138 371	−67 704	2024-02-29
11,74365 %	Semelin Kapitalförvaltning AB	5 992 338	−52 278	2024-02-29
1,67455 %	Nordea Funds Oy	854 458	−7 417	2024-02-29
1,26810 %	SEB Investment Management AB	647 063	−21 548	2024-02-29
1,24234 %	Norges Bank Investment Management (NBIM)	633 921	633 921	2023-12-31
0,87068 %	Amundi Asset Management, SAS	444 274	0	2024-03-31
0,70842 %	Lansförsäkringar Fondförvaltning AB	361 479	0	2024-02-29
0,69562 %	Enter Fonder AB	354 951	0	2023-12-31
0,69505 %	BlackRock Institutional Trust Company, N.A.	354 660	11 202	2024-03-31
0,67064 %	Hennermark (Gisli)	342 200	−21 000	2022-12-31
0,53869 %	Wellington Management Company, LLP	274 871	−844	2024-02-29
0,46643 %	Ålandsbanken Asset Management Ab	238 000	30 000	2024-02-29
0,36703 %	Deka Investment GmbH	187 280	−53 000	2022-12-31
0,34460 %	Evli Fund Management Company Ltd.	175 836	−30 218	2024-02-29
0,31742 %	Consensus Asset Management AB	161 966	−88 034	2023-01-31
0,26567 %	Columbia Threadneedle Investments (UK)	135 559	−99	2024-02-29
0,24301 %	FMR Investment Management (U.K.) Limited	124 000	0	2022-12-31
0,24301 %	Fidelity Management & Research Company LLC	124 000	0	2024-02-29
0,22987 %	Skandia Investment Management AB	117 296	0	2024-02-29
0,21863 %	Aperture Investors, LLC	111 557	0	2024-01-31
0,16443 %	SPSW Capital GmbH	83 900	−10 100	2024-01-31
0,13870 %	DNB Asset Management AS	70 773	4 825	2024-02-29
0,11759 %	Aktia Pankki Oyj	60 000	0	2024-02-29
0,11120 %	Coeli Asset Management AB	56 743	−36 257	2024-02-29
0,11018 %	Candriam Luxembourg S.A.	56 223	1 454	2024-02-29
0,09309 %	Larsson (Anders)	47 500	0	2022-12-31
0,09146 %	KLP Fondsforvaltning AS	46 668	−1 441	2024-02-29
0,07790 %	Invesco Advisers, Inc.	39 750	−977 237	2024-02-29
0,07632 %	California State Teachers Retirement System	38 945	6 923	2023-06-30
0,07068 %	Coeli Asset Management	36 063	−16 937	2024-02-29
0,07066 %	State Street Global Advisors (US)	36 057	0	2024-03-31
0,06676 %	UBS Asset Management (Switzerland)	34 067	0	2024-01-31
0,05760 %	BlackRock Advisors (UK) Limited	29 389	535	2024-03-31
0,05716 %	Nuveen LLC	29 166	0	2024-03-31
0,05691 %	DWS Investment GmbH	29 037	−81 237	2024-02-29
0,04966 %	Geode Capital Management, L.L.C.	25 341	0	2024-02-29
0,04409 %	Ahlberg (Anna)	22 500	0	2022-12-31
0,04326 %	Healthinvest Partners AB	22 072	0	2024-02-29
0,04325 %	Investitori SGR S.p.A.	22 068	−3 500	2024-02-29
0,04241 %	Bronstein (Ran)	21 638	0	2022-12-31
0,03634 %	Tal (Boaz CPA)	18 543	0	2022-12-31
0,03634 %	Mazor (Inbal)	18 543	0	2022-12-31
0,03474 %	Credit Suisse Funds AG	17 724	0	2024-02-29
0,03457 %	Seven Canyons Advisors, LLC	17 642	−23 783	2023-12-31
0,03454 %	The Vanguard Group, Inc.	17 627	0	2024-03-31
0,02744 %	ESALIENS TFI SA	14 000	0	2023-06-30
0,02739 %	BlackRock Asset Management Canada Limited	13 976	0	2024-03-31
0,02467 %	Northern Trust Global Investments Limited	12 589	0	2023-12-31
0,02150 %	Sensor Fonder AB	10 973	0	2024-01-31
0,02122 %	ETF Managers Group, LLC	10 830	−722	2023-11-30
0,02122 %	Cicero Fonder AB	10 829	5 000	2024-02-29
0,02042 %	Penserra Capital Management LLC	10 420	487	2024-03-31
0,01851 %	Florida State Board of Administration	9 444	9 444	2022-09-30
0,01744 %	Mercer Global Investments Management Ltd	8 901	0	2024-03-31
0,01663 %	State Street Global Advisors Ireland Limited	8 485	0	2024-03-31
0,01643 %	BlackRock Investment Management (UK) Ltd.	8 383	0	2023-12-31
0,01627 %	Nordea Investment Management AB (Denmark)	8 300	−500	2024-02-29
0,01619 %	UBS Asset Management (UK) Ltd.	8 262	0	2024-02-29
0,01302 %	Momentum Global Investment Management Limited	6 644	0	2022-08-31
0,01267 %	Storebrand Kapitalforvaltning AS	6 467	0	2024-02-29
0,01111 %	Russell Investments Limited	5 668	−108	2024-02-29
0,01100 %	Vanguard Investments Australia Ltd.	5 612	−1	2024-02-29
0,01009 %	Zilberman (Doron)	5 150	0	2022-12-31
0,00985 %	Boston Partners	5 028	0	2024-02-29
0,00980 %	Alphajet Fair Investors, SAS	5 000	0	2024-02-29
0,00944 %	IST Investmentstiftung	4 817	155	2024-02-29
0,00942 %	Zürcher Kantonalbank (Asset Management)	4 807	0	2024-01-31
0,00882 %	Mandarine Gestion	4 500	1 000	2024-02-29
0,00703 %	Legal & General Investment Management Ltd.	3 586	0	2024-03-31
0,00663 %	Columbia Threadneedle Management Limited	3 381	0	2024-02-29
0,00648 %	Ausbil Investment Management Limited	3 306	−899	2023-06-30
0,00432 %	Nykredit Bank AS	2 204	0	2024-02-29
0,00310 %	Northern Trust Investments, Inc.	1 584	0	2024-03-31
0,00301 %	Pictet Asset Management Ltd.	1 538	0	2023-11-30
0,00279 %	Amundi Ireland Limited	1 422	712	2024-02-29
0,00255 %	Hansson (Elisabeth)	1 300	0	2022-12-31
0,00196 %	Eklund (Thomas)	1 000	0	2022-12-31
0,00168 %	State Street Global Advisors (France) S.A.	856	−310	2023-10-31
0,00098 %	Falconer (Henrik)	500	291	2022-12-31
0,00044 %	American Century Investment Management, Inc.	225	84	2024-03-31
0,00027 %	Ericsson & Partners Formogenhetsforvaltning AB	138	−5 832	2023-04-30
0 %	FRAM Capital GmbH	0	−10 000	2023-12-31
0 %	Fidelity Investments Canada ULC	0	−4 118	2023-09-30
0 %	RAM Active Investments S.A.	0	−6 473	2023-12-31
0 %	Norron Asset Management AB	0	−61 113	2022-12-31
0 %	SOPRARNO SGR S.p.A.	0	−15 000	2024-02-29
0 %	FundLogic SAS	0	−5	2023-06-30
0 %	J. Chahine Capital	0	−2 491	2023-09-30
0 %	Dr. Blumer & Partner Asset Management AG	0	−10 883	2023-08-31
0 %	Neo Investimentos	0	−261	2023-09-30
0 %	Simplicity AB	0	−1 800	2023-09-30
0 %	DNCA Investments	0	−750 000	2023-03-31
0 %	Marlborough Fund Managers Ltd.	0	−999	2023-09-30

What values and corporate philosophy does Surgical Science Sweden represent?

Surgical Science Sweden AB represents a set of core values and corporate philosophy that drive its operations. The company prioritizes excellence in healthcare simulation technology, aiming to enhance medical training and patient safety worldwide. Surgical Science Sweden AB is committed to providing innovative and advanced solutions for surgical education, offering realistic simulators that mimic the human anatomy and empower medical professionals to develop their skills and expertise. With a focus on quality, the company strives for continuous improvement and collaboration with industry partners, ensuring its products are at the forefront of medical simulation. Surgical Science Sweden AB's dedication to delivering superior training tools makes it a trusted leader in the field.

In which countries and regions is Surgical Science Sweden primarily present?

Surgical Science Sweden AB is primarily present in several countries and regions worldwide. The company has a global presence, with a strong focus on Scandinavia, Europe, North America, and Asia. Surgical Science Sweden AB has established partnerships and collaborations with numerous medical institutions, universities, and healthcare providers in these regions, ensuring the widespread availability and adoption of their cutting-edge surgical simulators and training solutions. With their commitment to excellence and innovation, Surgical Science Sweden AB continues to expand its reach, delivering advanced medical training technology to professionals in various countries and regions across the globe.

What significant milestones has the company Surgical Science Sweden achieved?

Surgical Science Sweden AB has achieved significant milestones in its journey. The company has made remarkable advancements in the field of surgical simulation, providing cutting-edge training solutions to medical professionals worldwide. Surgical Science Sweden AB has received recognition for its high-quality simulators, which offer a realistic and immersive experience for trainees. The company's commitment to innovation has led to partnerships with renowned medical institutions, paving the way for research collaborations and improved training methods. Additionally, Surgical Science Sweden AB has expanded its global presence, establishing itself as a leader in surgical education.

What is the history and background of the company Surgical Science Sweden?

Surgical Science Sweden AB is a company with a rich history and background. Established in Sweden, the company has been a prominent player in the field of surgical simulation and training since its inception. With a focus on providing realistic and immersive training solutions for medical professionals, Surgical Science Sweden AB has developed cutting-edge technology and advanced simulators. Over the years, the company has gained recognition for its innovation, quality, and commitment to improving surgical education. With a strong presence in the global market, Surgical Science Sweden AB continues to lead the way in revolutionizing surgical training, ensuring safer and more efficient procedures for healthcare professionals worldwide.

Who are the main competitors of Surgical Science Sweden in the market?

The main competitors of Surgical Science Sweden AB in the market include other companies operating in the medical simulation industry. These competitors may include Simulab Corporation, CAE Healthcare, Mentice AB, and Limbs & Things Ltd. These companies offer similar products and solutions for medical training and simulation purposes, competing with Surgical Science Sweden AB in terms of product quality, pricing, and market share. Surgical Science Sweden AB strives to maintain its competitive edge by continually innovating and delivering high-quality medical simulation technology to its customers.

In which industries is Surgical Science Sweden primarily active?

Surgical Science Sweden AB is primarily active in the healthcare industry.

What is the business model of Surgical Science Sweden?

The business model of Surgical Science Sweden AB revolves around providing advanced medical simulation solutions. As a leading global supplier, Surgical Science focuses on developing and delivering high-fidelity simulators and software tools for medical training and education. These simulation solutions enable medical professionals to practice surgical procedures and enhance their skills in a safe and realistic environment. With a strong commitment to innovation and educational excellence, Surgical Science Sweden AB aims to improve patient safety and quality of care by offering state-of-the-art simulation technology to healthcare institutions and professionals worldwide.

Koks yra Surgical Science Sweden 2024 KGV?

Surgical Science Sweden KGV yra 32,93.

Koks Surgical Science Sweden 2024 KUV?

Surgical Science Sweden KUV yra 6,23.

Koks yra Surgical Science Sweden AlleAktien kokybės įvertinimas?

AlleAktien kokybės įvertis Surgical Science Sweden yra 3/10.

Koks yra Surgical Science Sweden 2024 pajamų dydis?

tikėtina Surgical Science Sweden pardavimai yra 934,45 mln. SEK.

Kokia yra Surgical Science Sweden 2024 pelnas?

tikėtina Surgical Science Sweden pelnas yra 176,67 mln. SEK.

Ką daro Surgical Science Sweden?

The company Surgical Science Sweden AB is an innovative company in the field of medical education. Founded in 1999, the company aims to improve the training of medical personnel by producing realistic simulators. The company places great emphasis on attention to detail and realistic simulation in order to ensure a high training quality. Surgical Science Sweden AB's business model is based on three areas of business: 1. Medical simulators Surgical Science Sweden AB produces a wide range of medical simulators that support the training of medical personnel in various areas. These include simulators for endovascular procedures, minimally invasive procedures, anesthesia, and resuscitation. The simulators are designed to be realistic and equipped with various scenarios to provide an effective training experience. 2. Training programs In addition to manufacturing medical simulators, Surgical Science Sweden AB also offers training programs tailored to the respective simulators. The training is provided by experienced instructors who support trainees in working with the simulators and provide feedback on their training. These training programs are an effective way to bring medical personnel up to date with the latest technology or acquire specific skills. 3. Maintenance and support Surgical Science Sweden AB also offers maintenance and support services for its medical simulators. These services are important to ensure that the simulators are always in perfect condition and ready for use at any time. In addition, the company also offers training in the use of the simulators and first-class technical support. Overall, Surgical Science Sweden AB has developed an innovative business model based on the production of realistic medical simulators, while also enabling high-quality training for medical personnel. The company has achieved its market position through a consistent focus on quality and innovation. The simulators from Surgical Science Sweden AB are used in leading medical training institutions worldwide, contributing to the improvement of medical personnel training and patient safety.

Kokia yra Surgical Science Sweden dividendė?

Surgical Science Sweden moka dividendą 0 SEK, kuris yra paskirstytas per išmokas per metus.

Kiek kartų Surgical Science Sweden moka dividendą?

Dividenda šiuo metu negali būti apskaičiuota Surgical Science Sweden arba įmonė dividendų nemoka.

Kas yra Surgical Science Sweden ISIN?

Surgical Science Sweden ISIN yra SE0014428512.

Kas yra Surgical Science Sweden WKN?

Surgical Science Sweden WKN yra A2P46G.

Kas yra Surgical Science Sweden Tickeris?

Surgical Science Sweden akcijų simbolis yra SUS.ST.

Kiek dividendų moka Surgical Science Sweden?

Per paskutinius 12 mėnesių Surgical Science Sweden išmokėjo dividendą, kurios dydis siekė . Tai atitinka maždaug dividendų grąžą. Artimiausiems 12 mėnesiams Surgical Science Sweden tikėtina išmokės dividendus, kurie sudarys 0 SEK.

Kokia yra Surgical Science Sweden dividendų grąža?

Surgical Science Sweden šiuo metu yra dydžio dividendų grąža.

Kada Surgical Science Sweden moka dividendus?

Surgical Science Sweden moka dividendus kas ketvirtį. Jie išmokami mėnesiais.

Kokia saugi yra Surgical Science Sweden dividendų išmokėjimas?

Surgical Science Sweden per paskutiniuosius 0 metus kiekvienais metais mokėjo dividendus.

Kokia yra Surgical Science Sweden dividendų suma?

Artimiausiems 12 mėnesiams tikimasi dividendų, kurių dydis yra 0 SEK. Tai atitinka 0 % dividendų grąžos procentą.

Kokiame sektoriuje yra Surgical Science Sweden?

Surgical Science Sweden priskiriamas sektoriui "Sveikata".

Wann musste ich die Aktien von Surgical Science Sweden kaufen, um die vorherige Dividende zu erhalten?

Norėdamas gauti paskutinį Surgical Science Sweden dividendą nuo 2024-09-09, kurio dydis yra 0 SEK, turėjai turėti akciją savo depozite prieš ex-dieną, kuri buvo 2024-09-09.

Kada Surgical Science Sweden paskutinį kartą mokėjo dividendą?

Paskutinės dividendų išmokėjimas įvyko 2024-09-09.

Kokia buvo Surgical Science Sweden dividendų suma 2023 metais?

2023 metais Surgical Science Sweden išmokėjo 0 SEK dividendų.

Kokia valiuta Surgical Science Sweden moka dividendus?

Surgical Science Sweden dividendai yra mokami SEK.

Birža	Surgical Science Sweden Akcijų kodas
DIUSELDORFAS	4P41.DU
FRANKFURTAS	4P41.F
LONDON	0AAU.L
MIUNCHENAS	4P41.MU
PNK	SUSRF
STOKHOLMAS	SUS.ST
STOKHOLMAS	SUS.ST

Surgical Science Sweden Akcijų kodas	Surgical Science Sweden FIGI
SUS:SF	BBG00GSNPLH1
SUSS:PO	BBG00JL6Z2B6
SUSSEK:XH	BBG00JL71ZQ2
SUSSEK:XF	BBG00JL71ZS0
SUSSEK:XE	BBG00JL71ZW5
SUSSEK:XL	BBG00JL71ZY3
SUSSEK:XG	BBG00JL71ZZ2
SUSSEK:XO	BBG00JL72006
SUSSEK:XA	BBG00JL72051
SUSSEK:XT	BBG00JL72079
SUSSEK:XW	BBG00JL72088
SUSSEK:XU	BBG00JL72097
SUSSEK:XV	BBG00JL720B4
SUSSEK:XM	BBG00JL720C3
SUSSEK:EU	BBG00JL720G9
SUSS:B3	BBG00JLWNRN4
SUSS:L3	BBG00JLX8M14
SUSRF:US	BBG00QRZR2Y4
SUSRF:PQ	BBG00QRZR3D5
SUSRF:UV	BBG00QRZR3F3
4P41:GZ	BBG00SJLTYV1
4P41:GR	BBG00SJLZHZ7
4P41:GF	BBG00SJLZJ01
4P41:GD	BBG00SJLZJ10
4P41:GS	BBG00SJLZJ38
4P41:GM	BBG00SJLZJ47
4P41:GB	BBG00SJLZJ56
4P41:GH	BBG00SJLZJ83
SUS1EUR:X2	BBG00SKFK143
SUS1EUR:XH	BBG00SKFK1K5
SUS1EUR:XF	BBG00SKFK1N2
SUS1EUR:XE	BBG00SKFK1X1
SUS1EUR:XL	BBG00SKFK205
SUS1EUR:XG	BBG00SKFK214
SUS1EUR:XO	BBG00SKFK287
SUS1EUR:XP	BBG00SKFK2L2
SUS1EUR:XA	BBG00SKFK2X9
SUS1EUR:XT	BBG00SKFK2Z7
SUS1EUR:XW	BBG00SKFK303
SUS1EUR:XU	BBG00SKFK312
SUS1EUR:XV	BBG00SKFK349
SUS1EUR:XM	BBG00SKFK358
SUS1EUR:X1	BBG00SKFK3N8
SUS1EUR:EU	BBG00SKFKMG4
SUSS:L1	BBG00Y935NV9
4P41:TH	BBG013GL9DV6
4P41:QT	BBG013K9X316
0AAU:LN	BBG015BB6ZV2
4P41:LA	BBG018H9VY95
4P41:LU	BBG018J3JH15
SUS1GBX:EO	BBG01KQ8DC16
SUS1GBX:X2	BBG01KQ8DC25
SUS1GBX:XH	BBG01KQ8DC43
SUS1GBX:XF	BBG01KQ8DC61
SUS1GBX:XE	BBG01KQ8DC89
SUS1GBX:XJ	BBG01KQ8DC98
SUS1GBX:XL	BBG01KQ8DCB5
SUS1GBX:XG	BBG01KQ8DCC4
SUS1GBX:XO	BBG01KQ8DCD3
SUS1GBX:XA	BBG01KQ8DCK5
SUS1GBX:E1	BBG01KQ8DCL4
SUS1GBX:XT	BBG01KQ8DCM3
SUS1GBX:XW	BBG01KQ8DCN2
SUS1GBX:XU	BBG01KQ8DCP0
SUS1GBX:XY	BBG01KQ8DCQ9
SUS1GBX:XV	BBG01KQ8DCR8
SUS1GBX:XM	BBG01KQ8DCS7
SUS1GBX:XQ	BBG01KQ8DCT6
SUS1GBX:XX	BBG01KQ8DCV3
SUS1GBX:XZ	BBG01KQ8DCW2
SUS1GBX:X1	BBG01KQ8DCY0
SUS1GBX:EU	BBG01KQ8DD78

Padaryk geriausias savo gyvenimo investicijas fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Kursas

Akcijos kaina

Akcijų kodasSUS.ST

ISINSE0014428512

VVPA2P46G

Surgical Science Sweden akcijų kaina

Kursas

Apžvalga

Intraday funkcija

Bendroji grąža ir santykinė kainų pokyčiai

Interpretacija ir investavimas

Surgical Science Sweden Akcijų istorija

Surgical Science Sweden akcijų apyvarta, EBIT, pelnas SE0014428512 · A2P46G

Pajamos, pelnas & EBIT

Supratimas apie pajamas, EBIT ir pelną

Metinė analizė ir palyginimai

Išnaudoti lūkesčius investuojant

Investicijų įžvalgos

Surgical Science Sweden Pajamų, pelno ir EBIT istorija.

Surgical Science Sweden Akcijų rodikliai

GuV

Pajamos ir augimas

Bruto marža

EBIT ir EBIT marža

Pajamos ir jų augimas

Leidžiamų akcijų skaičius

Metinių duomenų palyginimo interpretacija

Lūkesčiai ir prognozės

Balansas

Balanso supratimas

Turtas

Įsipareigojimai

Nuosavas kapitalas

Metų po metų analizė

Duomenų interpretacija

Surgical Science Sweden Akcijos Maržos SE0014428512 · A2P46G

Margen

Supratimas apie bruto maržą

EBIT maržos analizė

Pardavimų maržos įžvalgos

Lūkesčių interpretavimas

Lyginamoji analizė

Surgical Science Sweden Maržų istorija

Surgical Science Sweden akcijos apyvarta, EBIT, pelnas vienai akcijai SE0014428512 · A2P46G

Pardavimai, EBIT ir Pelnas vienai akcijai

Pajamos vienai akcijai

EBIT vienai akcijai

Pelnas vienai akcijai

Tikėtinos vertės

Surgical Science Sweden Pardavimų, pelno ir EBIT istorija vienai akcijai

Surgical Science Sweden akcija ir akcijų analizė

Surgical Science Sweden vertinimas pagal Fair Value

Fair Value

Supratimas apie Fair Value

Pajamų pagrindu skaičiuojamas Fair Value

Apyvartos pagrindu skaičiuojamas Fair Value

Dividendų pagrindu skaičiuojamas Fair Value

Lūkesčiai ir prognozės

Palyginamoji analizė

Surgical Science Sweden įvertinimas pagal istorinį P/E, EBIT ir P/S

Surgical Science Sweden akcijų skaičius SE0014428512 · A2P46G

Pardavimai, EBIT ir Pelnas vienai akcijai

Pajamos vienai akcijai

EBIT vienai akcijai

Pelnas vienai akcijai

Tikėtinos vertės

Surgical Science Sweden Akcijų padalijimai

Surgical Science Sweden Pelno prognozės

Surgical Science Sweden Pelnų staigmenos

Surgical Science Sweden akcijos akcininkų struktūra

Dažnai užduodami klausimai apie Surgical Science Sweden akciją

What values and corporate philosophy does Surgical Science Sweden represent?

In which countries and regions is Surgical Science Sweden primarily present?

What significant milestones has the company Surgical Science Sweden achieved?

What is the history and background of the company Surgical Science Sweden?

Who are the main competitors of Surgical Science Sweden in the market?

In which industries is Surgical Science Sweden primarily active?

What is the business model of Surgical Science Sweden?

Koks yra Surgical Science Sweden 2024 KGV?

Padaryk geriausias savo gyvenimo investicijas
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Akcijų kodas
SUS.ST

ISIN
SE0014428512

VVP
A2P46G